Menu

© 2026 MetaFit. Your health, simplified.

GLP-1 Side Effects: What to Expect and How to Manage Them
Back to Blog

GLP-1 Side Effects: What to Expect and How to Manage Them

M
MetaFit Medical Team1 July 2024
5 min read
Medically reviewed by Dr. Arjun Nair, MD, DM Head of Clinical, MetaFit
Nausea, bloating, constipation — GLP-1 side effects are real but manageable. Here's MetaFit's evidence-based guide to handling them.

Let's Be Honest About Side Effects

Every medication has side effects, and GLP-1 drugs are no exception. The difference is that most GLP-1 side effects are temporary, predictable, and manageable — especially when you have a medical team guiding you through the initial adjustment period. Here's what the data actually shows.

The Most Common Side Effects

🤢
Nausea (40–50% of users)

Most common in weeks 1–4. Usually mild to moderate. Eating smaller, more frequent meals and avoiding fatty foods helps significantly.

💨
Bloating & Gas (20–30%)

GLP-1 slows gastric emptying, which can cause fullness and bloating. This typically resolves as your body adjusts over 4–6 weeks.

🚽
Constipation or Diarrhea (15–25%)

Staying hydrated, eating fibre-rich foods, and gentle movement after meals can prevent most digestive issues.

😴
Fatigue (10–15%)

Often related to reduced caloric intake. Ensuring adequate protein and hydration resolves this for most users.

MetaFit's Slow-Titration Protocol

The biggest mistake people make with GLP-1 drugs is starting at too high a dose too quickly. MetaFit's doctors use a gradual titration protocol — starting at the lowest effective dose and increasing slowly over weeks. This approach dramatically reduces side effect severity and dropout rates.

✅ MetaFit's Side Effect Management

  • Gradual dose titration over 8–12 weeks
  • Weekly check-ins during adjustment phase
  • Personalized diet modifications to minimize GI symptoms
  • 24/7 chat access to your care team

Explore the topic

References

  1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021 (STEP 1) — mean 14.9% body-weight reduction at 68 weeks.
  2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022 (SURMOUNT-1) — up to 20.9% body-weight reduction at 72 weeks.

This article is for general information and is not a substitute for individual medical advice. Prescription medicines referenced here are regulated in India by the Central Drugs Standard Control Organisation (CDSCO) and are dispensed only against a valid prescription from a registered medical practitioner.

Ready to Start Your Weight Loss Journey?

Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.

Book a Free Consultation

Or download the app to get started

More Articles

Start Your Journey